
CSL, the world's second biggest blood products maker, says it will buy back up to $900 million of its own shares and reaffirmed its earlier profit guidance, saying the business was trading in line with its expectations. "CSL will conduct a further on ... CSL plans $900m share buyback
No comments:
Post a Comment